BLRX - BioLineRx announces closing of exclusive license agreement with GloriaBio October, 12 2023 09:43 AM BioLineRx Ltd. 2023-10-12 09:43:09 ET More on biolinerx BioLineRx gains after winning first FDA approval BioLineRx GAAP EPS of -$0.02 Seeking Alpha’s Quant Rating on biolinerx For further details see: BioLineRx announces closing of exclusive license agreement with GloriaBio